Module 4 Quiz
QUESTIONS 1-8 (1 point each) True o r f a l se qu e s t i o n s. True False 1) Positive predictive value is more influenced by the sensitivity than the specificity of the screening test. True False 2) A test can be reliable and not valid. True False 3) Increasing the prevalence of a disease will result in an increase in the positive predictive value of the screening test. True False 4) The sensitivity of a screening test depends on the incidence of disease in the population. True False 5) The increase in incidence of the target disease in a given population, will likely increase its implementation as a widely used new screening test in this community. True False 6) Specificity answers the question: “Of all individuals that are free of disease A, what proportion test negative for this disease?” True False 7) Successful treatment programs that shorten the duration of a disease primarily affect the prevalence of the disease rather than the incidence rate. True False 8) The preclinical phase of disease lasts from the biological onset to the development of symptoms. 9. Name the population factor that affects positive predictive value: __________ (1 point) 10. The reliability of a screening test refers to: (1 point) A. validity B. accuracy C. Repeatability D. predictive value This study source was downloaded by from CourseH on :13:38 GMT -05:00 2 11. Which of the following statements describes the Kappa Statistic? (1 point) A. A Kappa value of 0.40 represents excellent agreement B. The Kappa statistic is a measure of agreement C. The Kappa statistic is a measure of reliability D. Both B and C. E. All of the above Use the following information for questions 12-15. (2 points each) The following question is loosely based off of data and methods from a study by Flores-Chavez, et al. (2012) on a new diagnostic tool for testing various parasitic diseases in Spain. Flores-Chavez, M., et al. 2012. “Sensitivity and Specificity of an Operon Immunochromatographic Test in Serum and Whole-Blood Samples for Diagnosis of Typanosoma cruzi infections in Spain, an Area of nonendemicity.” Clin Vaccin Immunol. 19(9):
Información del documento
- Subido en
- 21 de octubre de 2022
- Número de páginas
- 6
- Escrito en
- 2022/2023
- Tipo
- Examen
- Contiene
- Desconocido